Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1–40/42 and Phospho-Tau May Abet Alzheimer Development
Open Access
- 19 February 2016
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 65 (7) , 1892-1903
Abstract
Increased coexistence of Alzheimer disease (AD) and type 2 diabetes mellitus (T2DM) suggests that insulin resistance abets neurodegenerative processes, but linkage mechanisms are obscure. Here, we examined insulin signaling factors in brains of insulin-resistant high-fat–fed mice, ob/ob mice, mice with genetically impaired muscle glucose transport, and monkeys with diet-dependent long-standing obesity/T2DM. In each model, the resting/basal activities of insulin-regulated brain protein kinases, Akt and atypical protein kinase C (aPKC), were maximally increased. Moreover, Akt hyperactivation was accompanied by hyperphosphorylation of substrates glycogen synthase kinase-3β and mammalian target of rapamycin and FOXO proteins FOXO1, FOXO3A, and FOXO4 and decreased peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α) expression. Akt hyperactivation was confirmed in individual neurons of anterocortical and hippocampal regions that house cognition/memory centers. Remarkably, β-amyloid (Aβ1–40/42) peptide levels were as follows: increased in the short term by insulin in normal mice, increased basally in insulin-resistant mice and monkeys, and accompanied by diminished amyloid precursor protein in monkeys. Phosphorylated tau levels were increased in ob/ob mice and T2DM monkeys. Importantly, with correction of hyperinsulinemia by inhibition of hepatic aPKC and improvement in systemic insulin resistance, brain insulin signaling normalized. As FOXOs and PGC-1α are essential for memory and long-term neuronal function and regeneration and as Aβ1–40/42 and phospho-tau may increase interneuronal plaques and intraneuronal tangles, presently observed aberrations in hyperinsulinemic states may participate in linking insulin resistance to AD.Keywords
Funding Information
- National Institutes of Health (RO1-DK-065969-09)
This publication has 53 references indexed in Scilit:
- FoxO6 regulates memory consolidation and synaptic functionGenes & Development, 2012
- Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitorsDiabetologia, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- FoxO3 Regulates Neural Stem Cell HomeostasisCell Stem Cell, 2009
- FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell HomeostasisCell Stem Cell, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral ManifestationBiological Psychiatry, 2009
- FoxO transcription factors in the maintenance of cellular homeostasis during agingCurrent Opinion in Cell Biology, 2008
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degenerationEuropean Journal of Neuroscience, 2007